Hereditary Hemorrhagic Telangiectasia (HHT) Center
Status: Forecasted
Posted date: June 8, 2026
Archive date: August 30, 2026
Close date: July 10, 2026
Opportunity ID: 361511
Opportunity number: HRSA-26-092
Opportunity category: Discretionary
Agency name: Health Resources and Services Administration
Agency code: HHS-HRSA
Award floor: $0
Award ceiling: $2,900,000
Cost sharing required: No
Funding Instrument Types
- Cooperative Agreement
Category of Funding Activity
- Health
Eligible Applicants
- State governments
- Unrestricted
Categories (use these for quoted searches)
- agency_code:hhs_hrsa
- category_of_funding_activity:health
- cost_sharing_or_matching_requirement:false
- eligible_applicants:state_governments
- eligible_applicants:unrestricted
- funding_instrument_type:cooperative_agreement
- opportunity_category:discretionary
- status:forecasted
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.